| |
 |
|
|
|
Wilex is a Germany biopharmaceutical company developing novel cancer therapies. Three compounds are in clinical development - Rencarex® in Phase III to treat renal cell cancer, and WX-G250 and WX-671, both in Phase I/II to treat breast cancer and other solid tumors.
www.wilex.com
|
|
| |
|
|
|
